WASHINGTON, D.C. — In the wake of the House passage today of H.R. 3, The Lower Drug Costs Now Act, the American Psychiatric Association (APA) announced its support for several provisions in the bill that benefit mental health care.
In addition to efforts that limit out-of-pocket costs for our patients, APA appreciates the House’s attention in H.R. 3 to additional investments to stem the opioid epidemic, fund Community Health Centers, increase resources devoted to the Precision Medicine Initiative and the BRAIN Initiative of the National Institutes of Health, boost financial support to help low income seniors afford their prescription drugs, and provide a modest two-year update for physicians’ services.
“These provisions will help us address the opioid epidemic and fund important research that will...Read More